223 related articles for article (PubMed ID: 21145853)
1. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections.
Oliviero B; Cerino A; Varchetta S; Paudice E; Pai S; Ludovisi S; Zaramella M; Michelone G; Pugnale P; Negro F; Barnaba V; Mondelli MU
J Hepatol; 2011 Jul; 55(1):53-60. PubMed ID: 21145853
[TBL] [Abstract][Full Text] [Related]
2. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
[TBL] [Abstract][Full Text] [Related]
3. Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation.
Oliviero B; Mantovani S; Ludovisi S; Varchetta S; Mele D; Paolucci S; Baldanti F; Mondelli MU
J Viral Hepat; 2015 Apr; 22(4):391-8. PubMed ID: 25258145
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
[TBL] [Abstract][Full Text] [Related]
5. Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus.
Fournillier A; Freida D; Defrance T; Merle P; Trépo C; Inchauspé G
J Med Virol; 2004 Apr; 72(4):566-74. PubMed ID: 14981759
[TBL] [Abstract][Full Text] [Related]
6. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
9. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
Semmo N; Krashias G; Willberg C; Klenerman P
J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
[TBL] [Abstract][Full Text] [Related]
11. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
[TBL] [Abstract][Full Text] [Related]
12. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
13. Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients.
de Almeida CM; de Lima TA; Castro DB; Torres KL; da Silva Braga W; Peruhype-Magalhães V; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
Scand J Immunol; 2011 May; 73(5):486-95. PubMed ID: 21231952
[TBL] [Abstract][Full Text] [Related]
14. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
[TBL] [Abstract][Full Text] [Related]
15. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection.
Guido M; Thung SN; Fattovich G; Cusinato R; Leandro G; Cecchetto A; Cesaro S; Panese P; Rugge M
Mod Pathol; 1999 Jun; 12(6):599-603. PubMed ID: 10392636
[TBL] [Abstract][Full Text] [Related]
17. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection.
Tsubouchi E; Akbar SM; Horiike N; Onji M
J Gastroenterol; 2004 Aug; 39(8):754-62. PubMed ID: 15338369
[TBL] [Abstract][Full Text] [Related]
18. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
19. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
[TBL] [Abstract][Full Text] [Related]
20. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
